Other studies found that TREM2-APOE-C1Q- positive macrophages were associated with increased markers of T cell exhaustion (74) and pro-tumor M2 macrophages such as CD163 and MSR1 (40), which were associated with cancer clinicopathologic characteristics and outcomes (75). This evidence concerns the gene TREM2 and cancer.